Aug 31, 2022· Comment from Association for Accessible Medicines (AAM)· FDA-2022-D-0277-0023
FDA, Please find attached comments from the Association for Accessible Medicines regarding the draft Guidance for Industry, Risk Management Plans to Mitigate the Potential for Drug Shortages; Docket FDA-2022-D-0277. Thanks, Scott Kuzner Senior Director, Sciences and Regulatory Affairs Association for Accessible Medicines